Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, et al.

N Engl J Med. 1991 May 16;324(20):1385-93.

2.

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.

Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrovsky E, Warrell RP Jr.

Ann Intern Med. 1994 Feb 15;120(4):278-86.

PMID:
8291820
3.
5.

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.

Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr.

Blood. 1992 Jan 15;79(2):299-303. Erratum in: Blood 1992 Aug 1;80(3):855.

6.

[Remission of acute promyelocytic leukemia after all-trans-retinoic acid].

Knobel B, Sommer I, Meytes D.

Harefuah. 1992 Dec 1;123(11):445-8, 507. Hebrew.

PMID:
1487198
7.

Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.

Zhang JW, Wang JY, Chen SJ, Chen Z.

J Biosci. 2000 Sep;25(3):275-84. Review.

PMID:
11022230
8.

Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.

Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, DeBlasio A, Levine K, Evans RM, Dmitrovsky E.

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2694-8.

9.

Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.

Cornic M, Chomienne C.

Leuk Lymphoma. 1995 Jul;18(3-4):249-57. Review.

PMID:
8535190
10.

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, Ferro MT, Luño E, Sánchez J, Vellenga E, Rayón C, Milone G, de la Serna J, Rivas C, González JD, Tormo M, Amutio E, González M, Brunet S, Lowenberg B, Sanz MA.

Haematologica. 2010 Mar;95(3):424-31. doi: 10.3324/haematol.2009.013243. Epub 2009 Nov 10.

11.

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.

Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F.

Blood. 1996 Aug 15;88(4):1390-8.

12.

The "retinoic acid syndrome" in acute promyelocytic leukemia.

Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr.

Ann Intern Med. 1992 Aug 15;117(4):292-6.

PMID:
1637024
13.
14.

Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.

Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martiat P, Degos L, Chen Z, et al.

Leukemia. 1994 Feb;8(2):312-7.

PMID:
8309256
15.

Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F.

Blood. 1997 Aug 1;90(3):1014-21.

16.

Acute promyelocytic leukemia: from clinic to molecular biology.

Chen SJ, Wang ZY, Chen Z.

Stem Cells. 1995 Jan;13(1):22-31. Review.

PMID:
7719245
17.

[Proposals for the objective indices for evaluating the differentiation of leukemic cells by all-trans retinoic acid in the patients with acute promyelocytic leukemia].

Nakajima H, Kizaki M, Takayama N, Kawai Y, Watanabe K, Okamoto S, Ikeda Y.

Rinsho Ketsueki. 1996 Mar;37(3):208-13. Japanese.

PMID:
8727344
18.

Phenotypic reversion in acute promyelocytic leukemia.

Degos L.

Nouv Rev Fr Hematol. 1991;33(6):511-5. Review.

PMID:
1667950
19.
20.

Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines.

Morosetti R, Grignani F, Liberatore C, Pelicci PG, Schiller GJ, Kizaki M, Bartram CR, Miller CW, Koeffler HP.

Blood. 1996 May 15;87(10):4399-403.

Items per page

Supplemental Content

Write to the Help Desk